Tag: Novartis

Novartis Launches FocalView App, Providing Opportunity for Patients to Participate in Ophthalmology Clinical Trials from Home

05/07/2018 iData Research

Register to receive a free U.S. Market Report Suite for Diagnostic Ophthalmic Devices – MedSuite report synopsis and brochure Novartis announced the launch of its FocalView app, an ophthalmic digi... Read More

Biosimilars – A Game Changer in the Immunology Rheumatoid Arthritis Market

17/10/2017 iData Research

Biosimilars are, as the name would suggest, highly similar and are a more affordable alternative to biologics that is poised to influence the current dynamics of the immunology market. ... Read More

Sandoz Erelzi™ (etanercept) Receives Positive Reimbursement Recommendation from Common Drug Review for Treatment of Multiple Inflammatory Diseases

21/08/2017 iData Research

Sandoz, a Novartis division, recently announced that The Canadian Drug Expert Committee (CDEC) as part of the Common Drug Review (CDR) process has issued a positive drug reimbursement recommendation f... Read More